Skip to content
2000
Volume 11, Issue 3
  • ISSN: 1871-5257
  • E-ISSN: 1875-6182

Abstract

Cardioprotective effect of resveratrol and resveratroloside was determined in ischemia-reperfusion experiments on rats. It was found that single intraperitoneal administration of any compound (10 mg/kg) followed by 30-min ischemia and 120-min reperfusion resulted in statistically significant decrease of myocardial infarct area (55.0±4.0% for control group; 40.7±4.4% for the group 1 received resveratrol; 41.6±4.8% for the group 2 received resveratroloside). The cardioprotective effect of resveratroloside was detected for the first time.

Loading

Article metrics loading...

/content/journals/chamc/10.2174/187152571103140120103302
2013-09-01
2025-12-08
Loading full text...

Full text loading...

/content/journals/chamc/10.2174/187152571103140120103302
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test